Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$0.51 - $0.67 $21,484 - $28,225
-42,127 Reduced 98.79%
514 $0
Q4 2022

Jan 30, 2023

BUY
$0.48 - $5.33 $37 - $415
78 Added 0.18%
42,641 $27,000
Q3 2022

Nov 08, 2022

BUY
$4.65 - $7.37 $1,357 - $2,152
292 Added 0.69%
42,563 $206,000
Q2 2022

Aug 04, 2022

SELL
$4.21 - $11.15 $244,377 - $647,224
-58,047 Reduced 57.86%
42,271 $195,000
Q1 2022

May 05, 2022

BUY
$8.48 - $18.1 $121,374 - $259,065
14,313 Added 16.64%
100,318 $1.08 Million
Q4 2021

Feb 02, 2022

BUY
$15.37 - $22.5 $239,449 - $350,527
15,579 Added 22.12%
86,005 $1.47 Million
Q3 2021

Nov 02, 2021

BUY
$15.05 - $23.28 $142,267 - $220,065
9,453 Added 15.5%
70,426 $1.26 Million
Q2 2021

Aug 02, 2021

BUY
$15.31 - $24.63 $630,190 - $1.01 Million
41,162 Added 207.77%
60,973 $1.18 Million
Q1 2021

May 11, 2021

BUY
$24.23 - $27.06 $480,020 - $536,085
19,811 New
19,811 $497,000

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.67B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.